{{Rsnum
|rsid=9480865
|Gene=FOXO3
|Chromosome=6
|position=108595370
|Orientation=plus
|GMAF=0.1621
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=FOXO3
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 2.7 | 31.9 | 65.5
| HCB | 0.0 | 8.8 | 91.2
| JPT | 0.0 | 11.5 | 88.5
| YRI | 10.2 | 40.1 | 49.7
| ASW | 5.3 | 38.6 | 56.1
| CHB | 0.0 | 8.8 | 91.2
| CHD | 0.9 | 9.3 | 89.8
| GIH | 3.0 | 15.8 | 81.2
| LWK | 5.5 | 35.5 | 59.1
| MEX | 3.4 | 36.2 | 60.3
| MKK | 3.8 | 39.1 | 57.1
| TSI | 6.9 | 32.4 | 60.8
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19010793
|Trait=Normalized brain volume
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000007
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs9480865
|Name_s=
|Gene_s=FOXO3, FOXO3A
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 753 cases, 883 controls; Replication Sample Size: NR); (Region: 6q21; Reported Gene(s): FOXO3; Risk Allele: rs9480865-?); (p-value= 0.000007).This variant is associated with Normalized brain volume.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740740
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs9480865
|overall_frequency_n=19
|overall_frequency_d=126
|overall_frequency=0.150794
|n_genomes=16
|n_genomes_annotated=0
|n_haplomes=18
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
|n_web_uneval=10
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}